11 research outputs found

    Repositioning of the global epicentre of non-optimal cholesterol

    Get PDF
    High blood cholesterol is typically considered a feature of wealthy western countries1,2. However, dietary and behavioural determinants of blood cholesterol are changing rapidly throughout the world3 and countries are using lipid-lowering medications at varying rates. These changes can have distinct effects on the levels of high-density lipoprotein (HDL) cholesterol and non-HDL cholesterol, which have different effects on human health4,5. However, the trends of HDL and non-HDL cholesterol levels over time have not been previously reported in a global analysis. Here we pooled 1,127 population-based studies that measured blood lipids in 102.6 million individuals aged 18 years and older to estimate trends from 1980 to 2018 in mean total, non-HDL and HDL cholesterol levels for 200 countries. Globally, there was little change in total or non-HDL cholesterol from 1980 to 2018. This was a net effect of increases in low- and middle-income countries, especially in east and southeast Asia, and decreases in high-income western countries, especially those in northwestern Europe, and in central and eastern Europe. As a result, countries with the highest level of non-HDL cholesterol—which is a marker of cardiovascular risk—changed from those in western Europe such as Belgium, Finland, Greenland, Iceland, Norway, Sweden, Switzerland and Malta in 1980 to those in Asia and the Pacific, such as Tokelau, Malaysia, The Philippines and Thailand. In 2017, high non-HDL cholesterol was responsible for an estimated 3.9 million (95% credible interval 3.7 million–4.2 million) worldwide deaths, half of which occurred in east, southeast and south Asia. The global repositioning of lipid-related risk, with non-optimal cholesterol shifting from a distinct feature of high-income countries in northwestern Europe, north America and Australasia to one that affects countries in east and southeast Asia and Oceania should motivate the use of population-based policies and personal interventions to improve nutrition and enhance access to treatment throughout the world.</p

    Repositioning of the global epicentre of non-optimal cholesterol

    Get PDF
    High blood cholesterol is typically considered a feature of wealthy western countries1,2. However, dietary and behavioural determinants of blood cholesterol are changing rapidly throughout the world3 and countries are using lipid-lowering medications at varying rates. These changes can have distinct effects on the levels of high-density lipoprotein (HDL) cholesterol and non-HDL cholesterol, which have different effects on human health4,5. However, the trends of HDL and non-HDL cholesterol levels over time have not been previously reported in a global analysis. Here we pooled 1,127 population-based studies that measured blood lipids in 102.6 million individuals aged 18 years and older to estimate trends from 1980 to 2018 in mean total, non-HDL and HDL cholesterol levels for 200 countries. Globally, there was little change in total or non-HDL cholesterol from 1980 to 2018. This was a net effect of increases in low- and middle-income countries, especially in east and southeast Asia, and decreases in high-income western countries, especially those in northwestern Europe, and in central and eastern Europe. As a result, countries with the highest level of non-HDL cholesterol�which is a marker of cardiovascular risk�changed from those in western Europe such as Belgium, Finland, Greenland, Iceland, Norway, Sweden, Switzerland and Malta in 1980 to those in Asia and the Pacific, such as Tokelau, Malaysia, The Philippines and Thailand. In 2017, high non-HDL cholesterol was responsible for an estimated 3.9 million (95 credible interval 3.7 million�4.2 million) worldwide deaths, half of which occurred in east, southeast and south Asia. The global repositioning of lipid-related risk, with non-optimal cholesterol shifting from a distinct feature of high-income countries in northwestern Europe, north America and Australasia to one that affects countries in east and southeast Asia and Oceania should motivate the use of population-based policies and personal interventions to improve nutrition and enhance access to treatment throughout the world. © 2020, The Author(s), under exclusive licence to Springer Nature Limited

    Four centuries of vegetation change in the mid-elevation Andean forests of Ecuador

    Get PDF
    Mid-elevation Andean ecosystems have immense species richness and endemism. Taxonomic composition is known to change through time on the eastern slopes of the Andes as a result of climatic change and disturbance events, both natural and by human actions. Fossil phytoliths can capture local scale vegetation changes, especially among monocotyledonous plants. Phytolith production is high in grasses and palms, plant groups that are particularly sensitive to climatic changes and disturbance events in Andean ecosystems. Here, we reconstruct four centuries of local-scale vegetation change and the corresponding fire history from lake sediment records retrieved from Lagunas Cormorán and Chimerella, located at ca. 1,700 m a.s.l. in the mid-elevation Andean forests of eastern Ecuador. The charcoal analysis of the lake sediments showed no sign of past fires, and no evidence of cultivation was found at either lake. The phytolith assemblages indicated changes in the relative abundances of palms, grasses and trees over the last few centuries, suggesting that mid-elevation Andean phytolith assemblages are sensitive to local scale vegetation dynamics. The largest change in vegetation occurred at the end of the Little Ice Age, at which point the diversity of palm phytoliths decreases. These phytolith assemblages are probably responding to changes in the cloud base position through time, which strongly influences the distributions of many plants and animals

    Comparison of HRRT and HR plus Scanners for Quantitative (R)-[C-11]verapamil, [C-11]raclopride and [C-11]flumazenil Brain Studies

    No full text
    Purpose: This study was conducted to directly compare the high-resolution research tomograph (HRRT) (high-resolution brain) and HR+ (standard whole-body) positron emission tomography (PET) only scanners for quantitative brain studies using three tracers with vastly different tracer distributions.Procedures: Healthy volunteers underwent successive scans on HR+ and HRRT scanners (in random order) using either (R)-[11C]verapamil (n = 6), [11C]raclopride (n = 7) or [11C]flumazenil (n = 7). For all tracers, metabolite-corrected plasma-input functions were generated.Results: After resolution matching, HRRT-derived kinetic parameter values correlated well with those of HR+ for all tracers (intraclass correlation coefficients ≥0.78), having a good absolute interscanner test-retest variability (≤15 %). However, systematic differences can be seen for HRRT-derived kinetic parameter values (range −13 to +15 %).Conclusion: Quantification of kinetic parameters based on plasma-input models leads to comparable results when spatial resolution between HRRT and HR+ data is matched. When using reference-tissue models, differences remain that are likely caused by differences in attenuation and scatter corrections and/or image reconstruction

    Errores numéricos: ¿Cómo afectan a las personas con ansiedad matemática?

    Get PDF
    ¿Cómo responde el cerebro de una persona con ansiedad a las matemáticas? Nuestro estudio muestra que los estudiantes con mucha ansiedad hacia las matemáticas presentan un componente llamado negatividad asociada al error (NAE) de mayor tamaño que aquellos con poca ansiedad. Esta diferencia emerge en errores en tareas numéricas, lo que sugiere que las personas con alta ansiedad son hipersensibles a la comisión de estos errores. Este hallazgo aporta nuevo conocimiento sobre las bases cerebrales de la ansiedad hacia las matemáticas y sugiere que esta hipersensibilidad al error numérico podría ser un factor determinante tanto en el origen como en el mantenimiento de esta ansiedad
    corecore